ASX Announcement

NEU receives FDA minutes and re-confirms Phase 3 endpoints

Published: 13/05/25, 02:06pm (AEST)2 pages
Neuren Pharmaceuticals
NEU:ASXHealthcare

Recent NEU Announcements

Price Sensitive only